QA: Viracta Therapeutics Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2013_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 72,932,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 43,000
3 remainder_Assets 42,000
4 LiabilitiesCurrent 31,741,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,175,000
9 ResearchAndDevelopmentExpense 29,185,000
10 remainder_Expenses 1,855,000
11 remainder_Revenues 3,754,000
12 remainder_NetIncome -7,490,000
13 remainder_ComprehensiveNetIncome 19,000
  yvar yval
0 Assets 73,017,000
1 Liabilities 31,741,000
2 Expenses 40,215,000
3 Revenues 3,754,000
4 StockholdersEquity 41,276,000
5 NetIncome -43,951,000
6 ComprehensiveNetIncome -43,941,500
7 BaseVar 78,118,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.879
9 EconomicCapitalRatio 2.20

Edgar->Model Mapping

Feature Distribution

Change over Time